Routine HIV screening among blood donors in Buenos Aires (Argentina): Results from six years’ experience and report of a single window-period donation

2007 ◽  
Vol 25 (2) ◽  
pp. 82-90 ◽  
Author(s):  
Silvina Alejandra Gendler ◽  
María Susana Pascuccio
2018 ◽  
Vol 17 (2) ◽  
pp. 91-95
Author(s):  
Terry W Rice ◽  
◽  
Patricia A. Brock ◽  
Carmen Gonzalez ◽  
Kelly W Merriman ◽  
...  

Treatment of human immunodeficiency virus(HIV) in cancer patients improves outcomes and reduces transmission of this oncogenic virus. HIV testing rates of cancer patients are similar to the general population (15-40%), despite the association with cancer. Our aim was to increase HIV screening in the Emergency Department(ED) of a comprehensive cancer center through a quality initiative. Testing increased significantly during the intervention (p<0.001; 0.15/day to 2.69/day). Seropositive HIV rate was 1.4% (12/852), with incidence of 0.3%. All patients were linked to care. Incident cases were between 36 and 55 years of age. Barriers encountered included confusion regarding the need for written consent for HIV testing, failure to consider ordering the test, and concerns regarding linkage to care.


2021 ◽  
Vol 8 (Supplement_1) ◽  
pp. S513-S513
Author(s):  
Elizabeth A Aguilera ◽  
Gilhen Rodriguez ◽  
Gabriela P Del Bianco ◽  
Gloria Heresi ◽  
James Murphy ◽  
...  

Abstract Background The Emergency Department (ED) at Memorial Hermann Hospital (MHH) - Texas Medical Center (TMC), Houston, Texas has a long established screening program targeted at detection of HIV infections. The impact of the COVID-19 pandemic on this screening program is unknown. Methods The Routine HIV screening program includes opt-out testing of all adults 18 years and older with Glasgow score &gt; 9. HIV 4th generation Ag/Ab screening, with reflex to Gennius confirmatory tests are used. Pre-pandemic (March 2019 to February 2020) to Pandemic period (March 2020 to February 2021) intervals were compared. Results 72,929 patients visited MHH_ED during the pre-pandemic period and 57,128 in the pandemic period, a 22% decline. The number of patients tested for HIV pre-pandemic was 9433 and 6718 pandemic, a 29% decline. When the pandemic year was parsed into first and last 6 months interval and compared to similar intervals in the year pre pandemic, 39% followed by 16% declines in HIV testing were found. In total, 354 patients were HIV positives, 209, (59%) in the pre-pandemic and 145 (41%) in the pandemic period.The reduction in new HIV infections found was directly proportional to the decline in patients visiting the MHH-ED where the percent of patients HIV positive was constant across intervals (2.21% vs 2.26%). Demographic and outcome characteristics were constant across the compared intervals. Conclusion The COVID -19 pandemic reduced detection of new HIV infections by screening in direct proportion to the reduction in MHH-ED patient visits. The impact of COVID-19 pandemic decreased with duration of the pandemic. Disclosures All Authors: No reported disclosures


2016 ◽  
Vol 131 (1_suppl) ◽  
pp. 30-40 ◽  
Author(s):  
Amy Nunn ◽  
Caitlin Towey ◽  
Philip A. Chan ◽  
Sharon Parker ◽  
Emily Nichols ◽  
...  

Vox Sanguinis ◽  
1994 ◽  
Vol 67 (4) ◽  
pp. 408-409
Author(s):  
Zulema Gutfraind ◽  
Jorgelina L. Blejer ◽  
Maria C. Saguier ◽  
Maria L. Gomez Carretero ◽  
Daniel A. Pirola ◽  
...  
Keyword(s):  

Author(s):  
Nanci Alves Salles ◽  
Anna Shoko Nishiya ◽  
Suzete Cleusa Ferreira ◽  
Vanderson Geraldo Rocha ◽  
Alfredo Mendrone-Junior

2016 ◽  
Vol 131 (1_suppl) ◽  
pp. 11-20 ◽  
Author(s):  
Vanessa Rodriguez ◽  
Deborah Lester ◽  
Alison Connelly-Flores ◽  
Franco A. Barsanti ◽  
Paloma Hernandez

Sign in / Sign up

Export Citation Format

Share Document